Previous studies have reported that lncRNA H19 was involved in CRC tumorigenicity, whereas Ohtsuka et al. underscored the H19-E2F1 cascade in CRC, that was, H19 activated E2F1 signaling pathway to promote cell proliferation and tumor growth (Ohtsuka et al., 2016). The gene discussed is H19; the disease is neoplasm.